K

Kyntra Bio Inc
D

KYNB

5.46000
USD
-0.84
(-13.33%)
مغلق
حجم التداول
200
الربح لكل سهم
-15
العائد الربحي
-
P/E
-1
حجم السوق
22,108,217

العنوان: Kyntra Bio Inc

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.